154 related articles for article (PubMed ID: 35017658)
1. Methylation-mediated silencing of protein kinase C zeta induces apoptosis avoidance through ATM/CHK2 inactivation in dedifferentiated chondrosarcoma.
Shimada E; Matsumoto Y; Nakagawa M; Susuki Y; Endo M; Setsu N; Fujiwara T; Iida K; Nabeshima A; Yahiro K; Kimura A; Hirose T; Kanahori M; Oyama R; Oda Y; Nakashima Y
Br J Cancer; 2022 May; 126(9):1289-1300. PubMed ID: 35017658
[TBL] [Abstract][Full Text] [Related]
2. Distinct IDH1/2-associated Methylation Profile and Enrichment of
Dermawan JKT; Nafa K; Mohanty A; Xu Y; Rijo I; Casanova J; Villafania L; Benhamida J; Kelly CM; Tap WD; Boland PJ; Fabbri N; Healey JH; Ladanyi M; Lu C; Hameed M
Cancer Res Commun; 2023 Mar; 3(3):431-443. PubMed ID: 36926116
[TBL] [Abstract][Full Text] [Related]
3. TCF-1 participates in the occurrence of dedifferentiated chondrosarcoma.
Xu X; Tang X; Guo W; Yang K; Ren T
Tumour Biol; 2016 Oct; 37(10):14129-14140. PubMed ID: 27522523
[TBL] [Abstract][Full Text] [Related]
4. Feedback regulation of methyl methanesulfonate and ultraviolet-sensitive gene clone 81 via ATM/Chk2 pathway contributes to the resistance of MCF-7 breast cancer cells to cisplatin.
Lv J; Qian Y; Ni X; Xu X; Dong X
Tumour Biol; 2017 Mar; 39(3):1010428317694307. PubMed ID: 28347251
[TBL] [Abstract][Full Text] [Related]
5. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics.
Sarkar R; Patra U; Lo M; Mukherjee A; Biswas A; Chawla-Sarkar M
Cell Microbiol; 2020 Mar; 22(3):e13149. PubMed ID: 31845505
[TBL] [Abstract][Full Text] [Related]
6. Different expression of Sox9 and Runx2 between chondrosarcoma and dedifferentiated chondrosarcoma cell line.
Tang X; Lu X; Guo W; Ren T; Zhao H; Zhao F; Tang G
Eur J Cancer Prev; 2010 Nov; 19(6):466-71. PubMed ID: 20683191
[TBL] [Abstract][Full Text] [Related]
7. Ataxia-Telangiectasia Mutated (ATM) Protein Signaling Participates in Development of Pulmonary Arterial Hypertension in Rats.
Hu F; Liu C; Liu H; Xie L; Yu L
Med Sci Monit; 2017 Sep; 23():4391-4400. PubMed ID: 28894083
[TBL] [Abstract][Full Text] [Related]
8. 53BP1 loss induces chemoresistance of colorectal cancer cells to 5-fluorouracil by inhibiting the ATM-CHK2-P53 pathway.
Yao J; Huang A; Zheng X; Liu T; Lin Z; Zhang S; Yang Q; Zhang T; Ma H
J Cancer Res Clin Oncol; 2017 Mar; 143(3):419-431. PubMed ID: 27838786
[TBL] [Abstract][Full Text] [Related]
9. Comparative analysis of miRNA expression in dedifferentiated and well-differentiated components of dedifferentiated chondrosarcoma.
Karras FS; Schreier J; Körber-Ferl K; Ullmann SR; Franke S; Roessner A; Jechorek D
Pathol Res Pract; 2023 Apr; 244():154414. PubMed ID: 36963273
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus X protein activates the ATM-Chk2 pathway and delays cell cycle progression.
Kim S; Lee HS; Ji JH; Cho MY; Yoo YS; Park YY; Cha HJ; Lee Y; Kim Y; Cho H
J Gen Virol; 2015 Aug; 96(8):2242-2251. PubMed ID: 25872745
[TBL] [Abstract][Full Text] [Related]
11. Sustained CHK2 activity, but not ATM activity, is critical to maintain a G1 arrest after DNA damage in untransformed cells.
García-Santisteban I; Llopis A; Krenning L; Vallejo-Rodríguez J; van den Broek B; Zubiaga AM; Medema RH
BMC Biol; 2021 Feb; 19(1):35. PubMed ID: 33607997
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitor chidamide induces growth inhibition and apoptosis in NK/T lymphoma cells through ATM-Chk2-p53-p21 signalling pathway.
Zhou J; Zhang C; Sui X; Cao S; Tang F; Sun S; Wang S; Chen B
Invest New Drugs; 2018 Aug; 36(4):571-580. PubMed ID: 29504068
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors.
Wang L; Yang L; Wang C; Zhao W; Ju Z; Zhang W; Shen J; Peng Y; An C; Luu YT; Song S; Yap TA; Ajani JA; Mills GB; Shen X; Peng G
J Clin Invest; 2020 Nov; 130(11):5951-5966. PubMed ID: 33016929
[TBL] [Abstract][Full Text] [Related]
14. Activation of ATM/Chk2 by Zanthoxylum armatum DC extract induces DNA damage and G1/S phase arrest in BRL 3A cells.
Jiang J; Huang Y; Wang W; Sun C; Liu Q; Chen Y; Hu T; Ma X; Peng C; Ma Y; Liu S; Rao C
J Ethnopharmacol; 2022 Feb; 284():114832. PubMed ID: 34775036
[TBL] [Abstract][Full Text] [Related]
15. Gallic acid causes inactivating phosphorylation of cdc25A/cdc25C-cdc2 via ATM-Chk2 activation, leading to cell cycle arrest, and induces apoptosis in human prostate carcinoma DU145 cells.
Agarwal C; Tyagi A; Agarwal R
Mol Cancer Ther; 2006 Dec; 5(12):3294-302. PubMed ID: 17172433
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MELK produces potential anti-tumour effects in bladder cancer by inducing G1/S cell cycle arrest via the ATM/CHK2/p53 pathway.
Chen S; Zhou Q; Guo Z; Wang Y; Wang L; Liu X; Lu M; Ju L; Xiao Y; Wang X
J Cell Mol Med; 2020 Jan; 24(2):1804-1821. PubMed ID: 31821699
[TBL] [Abstract][Full Text] [Related]
17. Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.
Hirao A; Cheung A; Duncan G; Girard PM; Elia AJ; Wakeham A; Okada H; Sarkissian T; Wong JA; Sakai T; De Stanchina E; Bristow RG; Suda T; Lowe SW; Jeggo PA; Elledge SJ; Mak TW
Mol Cell Biol; 2002 Sep; 22(18):6521-32. PubMed ID: 12192050
[TBL] [Abstract][Full Text] [Related]
18. ATM-dependent CHK2 activation induced by anticancer agent, irofulven.
Wang J; Wiltshire T; Wang Y; Mikell C; Burks J; Cunningham C; Van Laar ES; Waters SJ; Reed E; Wang W
J Biol Chem; 2004 Sep; 279(38):39584-92. PubMed ID: 15269203
[TBL] [Abstract][Full Text] [Related]
19. Titanium dioxide nanoparticles activate the ATM-Chk2 DNA damage response in human dermal fibroblasts.
Prasad RY; Chastain PD; Nikolaishvili-Feinberg N; Smeester L; Kaufmann WK; Fry RC
Nanotoxicology; 2013 Sep; 7(6):1111-9. PubMed ID: 22770119
[TBL] [Abstract][Full Text] [Related]
20. Lyn tyrosine kinase promotes silencing of ATM-dependent checkpoint signaling during recovery from DNA double-strand breaks.
Fukumoto Y; Kuki K; Morii M; Miura T; Honda T; Ishibashi K; Hasegawa H; Kubota S; Ide Y; Yamaguchi N; Nakayama Y; Yamaguchi N
Biochem Biophys Res Commun; 2014 Sep; 452(3):542-7. PubMed ID: 25173936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
